Cytosorbents Corp 8-K Summary: 2024 Annual Meeting Results
Business Context and Reporting Period
This Form 8-K reports the results of the 2024 Annual Meeting of Stockholders held by Cytosorbents Corporation on June 6, 2024. The filing details the voting outcomes for four specific proposals submitted to shareholders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results.
Material Changes and Voting Results
At the record date of April 12, 2024, there were 54,306,415 shares of Common Stock outstanding. A quorum was established with 40,028,453 shares represented. All four proposals were approved by the stockholders:
- Proposal 1 (Election of Directors): All five nominees were elected. Notably, Michael Bator received the highest number of "Against" votes (4,075,659) compared to other nominees, though he was still elected.
- Proposal 2 (Say-on-Pay): Advisory approval of executive compensation was granted with 24,276,512 votes "For" and 4,672,332 votes "Against".
- Proposal 3 (Plan Amendment): The amendment to the 2014 Long-term Incentive Plan was approved with 20,042,379 votes "For" and 8,960,225 votes "Against". This proposal received the highest opposition among the four items.
- Proposal 4 (Auditor Ratification): The appointment of WithumSmith+Brown, PC was ratified with 37,543,951 votes "For" and 1,433,165 votes "Against".
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, management commentary on operations, or specific risk factors. The document is limited to the procedural results of the shareholder vote.
Investor Verification Checklist
- Verify the specific terms of the approved amendment to the 2014 Long-term Incentive Plan.
- Review the proxy statement for details on the significant "Against" votes cast for Director Michael Bator and the Plan Amendment.
- Confirm the total number of broker non-votes (10,782,068) and their impact on the voting thresholds.
- Check subsequent filings for the company's Q2 2024 financial results, as this 8-K contains no financial data.